3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
6
Pancreatic Neoplasms
5
Stomach Neoplasms
4
Neoplasms
3
Fatigue
3
Carcinoma, Hepatocellular
3
Urinary Bladder Neoplasms
2
Sarcoma
2
Rectal Neoplasms
2
Prostatic Neoplasms
2
Pain
2
Lymphoma
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stress Disorders, Post-Traumatic
1
Recurrence
1
Ovarian Neoplasms
1
Myelodysplastic Syndromes
1
Melanoma
1
Lung Neoplasms
1
Locally Advanced Colorectal Cancer
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Kidney Neoplasms
1
Hemorrhage
1
Hematologic Neoplasms
1
Interventions
pembrolizumab
14
Nivolumab
6
Carboplatin
5
sargramostim
4
Fluorouracil
4
Drug Therapy
4
Thiotepa
3
Sorafenib
3
Radiotherapy
3
Ipilimumab
3
Interferon-alpha
3
Gemcitabine
3
Filgrastim
3
Counseling
3
Cetuximab
3
liposomal doxorubicin
2
ixabepilone
2
entinostat
2
cemiplimab
2
belinostat
2
atezolizumab
2
Temozolomide
2
Surveys and Questionnaires
2
Sirolimus
2
Psychiatric Rehabilitation
2
Polymerase Chain Reaction
2
Paclitaxel
2
Methods
2
Melphalan
2
Irinotecan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Palliative Care
×
Gastrointestinal
×
Clear all
NCT03652298
2026-03-13
NeuroPrevPTSD
Centre Oscar Lambret
Phase 2
Terminated
19 enrolled